Showing results (1511-1520 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|January 11, 2013
Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sitesMarion J J Kuper-Hommel, Saskia A M van de Schans, Gerard Vreugdenhil, et al.Leukemia & Lymphoma|December 29, 2012
Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myelomaAnnamaria Brioli, Martin F Kaiser, Charlotte Pawlyn, et al.Leukemia & Lymphoma|December 29, 2012
The significance of spliceosome mutations in chronic lymphocytic leukemiaUri Rozovski, Michael Keating, Zeev EstrovLeukemia & Lymphoma|February 28, 2013
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factorsDaan Dierickx, Thomas Tousseyn, Xavier Sagaert, et al.Leukemia & Lymphoma|March 5, 2013
External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphomaMatthias Schwenkglenks, Kate Louise Bendall, Alena M Pfeil, et al.Leukemia & Lymphoma|April 20, 2013
Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unitKathryn Jackson, Peter Mollee, Kirk Morris, et al.Leukemia & Lymphoma|April 20, 2013
Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysisJoanna Graczyk, Matthew C Cheung, Rena Buckstein, et al.Leukemia & Lymphoma|April 26, 2013
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibitionMatthew S Davids, Anthony Letai, Jennifer R BrownLeukemia & Lymphoma|April 26, 2013
Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemiaCecilia Abreu, Pilar Moreno, Florencia Palacios, et al.Leukemia & Lymphoma|May 25, 2013
Relationship between 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphomaYasumitsu Hirose, Hiroaki Suefuji, Hayato Kaida, et al.Pageof 998